BARRANQUILLA, COLOMBIA--(NewMediaWire - Dec 28, 2016)
- New Colombia Resources, Inc. ("the
Company") (OTC PINK: NEWC), a Colombian natural resource company
listed in the U.S. is pleased to post the laboratory results of
Sannabis' Cannabis Sativa Pure Extract. New Colombia Resources
joint venture, Sannabis, has been healing patients and saving lives
in Colombia with this extract since 2014. The landrace strain
used to produce this extract is a pure sativa native to
Colombia. To see the laboratory results, visit https://drive.google.com/open?id=0BxSKP5j2FlseMUt2STNIU2dyNnc
The test conducted by a licensed medical marijuana testing
facility showed a high 35% THC value as well as a .2%
B-Caryophyllene terpene value. This combination is exceptional
in treating a wide variety of ailments and gives the Company a
better understanding of why this extract has worked so well for
patients in Colombia, specifically for cancer and neurological
disorders. The Company is using this and other test results to
develop more medicines targeting different ailments. According
to published reports posted on the National Institute of Health's
Library of Medicine this terpene has the following potential
medical benefits:
These results will be used by New Colombia Resources to develop
a drug master file to be used for an application to the FDA for an
orphan drug designation for a neurological disorder. New
Colombia Resources' FDA consultant, Dr. Stanley Satz, believes the
HPLC chromatograms of the peaks show great promise to develop a
pharmaceutical product to treat various neurological disorders to
be announced soon. Company President, John Campo, met with Dr.
Satz recently to take the steps necessary to file for an orphan
drug application as soon as possible. Mr. Campo is back in
Colombia today to coordinate with the Universities that will help
conduct the research under the guidance of Dr. Satz, who recently
has been awarded another orphan drug designation with the FDA and
fully understands the steps needed to gain acceptance of the
application.
In addition to the FDA pharmaceutical drug being developed,
Sannabis has been producing medical marijuana products sold through
independent distributors and pharmacies throughout Colombia since
2014. New Colombia Resources' President, John Campo, was
featured in an article in Dinero Magazine in 2014 at the beginning
of Colombia's medical marijuana movement, since then medical
marijuana has been legalized by both a Presidential executive order
and a law passed by the legislature. To see the 2014 article,
visit http://www.dinero.com/edicion-impresa/negocios/articulo/medicamentos-legales-derivados-del-cannabis-marihuana/199474
The Company aims to become a world leader in high quality "Made
in Colombia" cannabis medicines. Sannabis is at the forefront
of the Colombian governments effort to be become a world leader in
cannabis research and development. New Colombia Resources is
applying to the U.S. Food and Drug Administration (FDA) for an
orphan drug designation of a cannabis based pharmaceutical product
with clinical trials to be done in Colombia, they will work with
Universities in Colombia and the U.S. to conduct research to be
admitted to the FDA.
Sannabis has geared up for a major international expansion by
planting thousands of plants of exclusive medical marijuana strains
native to Colombia. These strains include the world famous
Sativas, Punto Rojo and Mango Biche, these landrace strains are
sought out by top European seed banks, however, in order for these
strains to flourish and provide the most valuable terpenes and
cannabinoids they must be grown in their native
environment.
The U.S. and Canada do not have native landrace strains,
therefore, Sannabis will aggressively penetrate the North American
market to supply the best medicine available at the best value to
Americans. Several documentaries by international producers
are being filmed in the coming weeks that will educate the world on
the medicinal and social value of Colombian
cannabis. Inquiries are pouring in from all over the world and
the Company has ramped up to fulfill orders.
New Colombia Resources is also pleased to announce their auditor
is finalizing a review of their Form 10K to be filled with the
SEC. Additionally, shareholders can expect a significant
revenue producing announcement concerning their metallurgical coal
mining operations.
To view the Sannabis Medical Marijuana products catalog with
technical specifications or to purchase products,
visit http://www.sannabis.co/ver-catalogo
To view a nationally televised documentary about medical
marijuana in Colombia featuring Sannabis growers, patients, and
management visit the first video on http://www.sannabis.co/video.
Follow Sannabis on Facebook for photos and testimonials
at https://www.facebook.com/sannabis.cannamedicinal
New Colombia Resources, Inc.
New Colombia Resources, Inc. owns vast reserves of premium
metallurgical coal mining titles and a medical marijuana joint
venture in the Republic of Colombia. They are setting up a rock
mining operation to supply the major road and infrastructure
projects within miles of their properties. They own 100% of La
Tabaquera metallurgical coal mine in Colombia with an estimated 15-
17 million tonnes of reserves. They have an additional 1196 ha.
metallurgical coal mining title that they are negotiating to
develop with a foreign entity to build a coal fired power
plant. New Colombia Resources holds a significant position in
Sannabis SAS which legally produces medical marijuana products in
the Republic of Colombia, visit www.sannabis.co. For more information on the
Company visit www.newcolombiaresources.com
Forward Looking Statements
Forward Looking Statements; This Press Release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Act of
1934. A statement containing works such as "anticipate," "seek,"
intend," "believe," "plan," "estimate," "expect," "project,"
"plan," or similar phrases may be deemed "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Some or all of the events or results
anticipated by these forward-looking statements might not occur.
Factors that could cause or contribute to such differences include
financing, the future U.S. and global economies, the impact of
competition, and the Company's reliance on existing regulations.
New Colombia Resources, Inc. does not undertake any duty nor does
it intend to update the results of these forward-looking
statements.